Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Diabetes Mellitus, Type 2 1 Diabetes Mellitus 1

Interventions

pembrolizumab 185 Carboplatin 133 Paclitaxel 102 Cisplatin 102 Gemcitabine 86 Pemetrexed 80 durvalumab 75 Nivolumab 66 Docetaxel 56 atezolizumab 52 Bevacizumab 50 Cyclophosphamide 49 Dexamethasone 45 Capecitabine 45 Oxaliplatin 43 130-nm albumin-bound paclitaxel 42 Rituximab 40 Fulvestrant 39 Lenalidomide 38 Fluorouracil 38 Prednisone 32 osimertinib 31 olaparib 29 Leucovorin 29 venetoclax 28 fludarabine 28 Trastuzumab 27 Doxorubicin 27 Etoposide 25 Cetuximab 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × INDUSTRY × saxagliptin × Clear all

NCT07033585 2025-07-11

GD-T2D

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Diabetes Mellitus, Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon ⚡